This inventor holds 1 USPTO granted patent. Top assignee: Cisen Pharmaceutical Co., Ltd. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: The Innovations of Ming Zhou
Introduction
Ming Zhou is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific cancer pathways. His work is characterized by a commitment to advancing medical science and improving treatment options for patients.
Latest Patents
Ming Zhou holds a patent for an aminopyrimidine compound that acts as a CDK2/4/6 triple inhibitor. This innovative compound is represented by a specific formula and includes pharmaceutically acceptable salts. The application of this compound is aimed at preparing a medicament for treating solid tumors, showcasing Zhou's dedication to addressing critical health challenges.
Career Highlights
Zhou is currently employed at Cisen Pharmaceutical Co., Ltd., where he continues to push the boundaries of pharmaceutical research. His work has not only led to the development of new therapeutic agents but has also contributed to the broader understanding of cancer treatment mechanisms.
Collaborations
Ming Zhou collaborates with esteemed colleagues such as Zhaobing Xu and Yong Wang. Their combined expertise enhances the research environment and fosters innovation within their projects.
Conclusion
Ming Zhou's contributions to the field of pharmaceuticals, particularly through his patent on aminopyrimidine compounds, highlight his role as a key innovator in cancer treatment. His ongoing work at Cisen Pharmaceutical Co., Ltd. continues to pave the way for advancements in medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile